{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:15:14Z","timestamp":1793146514285,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) shows significant sensitivity to immune checkpoint inhibitors (ICIs). However, a considerable proportion of patients still exhibit primary or acquired resistance to ICIs. Until now, efficient and non-invasive biomarkers for accurately predicting immunotherapy efficacy remain unavailable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this multicenter study, we employed liquid chromatography\u2013mass spectrometry (LC\u2013MS) and enzyme-linked immunosorbent assay (ELISA) to identify and validate serum metabolites associated with response to immunotherapy. Using machine learning algorithms, we constructed a random forest predictive model based on a panel of five metabolites. This model, termed the 5-Metabolite Predictive Model (5-MPM), incorporates prostaglandin E2 (PGE2), tryptophan, arginine, citrulline, and histidine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 5-MPM model demonstrated robust predictive performance in both training cohort and external validation cohort, with AUC values of 0.85 and 0.88, respectively. The SHAP analysis elucidated the contribution of each metabolite to model predictions. Integrating above five metabolites with metastasis stage did not further improve the predictive performance of this model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study provides the first systematic characterization of metabolic reprogramming in dMMR colorectal cancer with different response to immunotherapy, and establishes a non-invasive, high-precision predictive tool that offers a new basis for individualized therapeutic decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1730155","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:23:45Z","timestamp":1771478625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A serum metabolite-based machine learning model predicts response to neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Tao","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Pancreatic Hepatobiliary Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center","place":["Guangzhou, Guangdong, China"]},{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Pan","sequence":"additional","affiliation":[{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojie","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Hepatobiliary Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwei","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Hepatobiliary Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Hepatobiliary Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Bai","sequence":"additional","affiliation":[{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Hepatobiliary Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Hu","sequence":"additional","affiliation":[{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Sun Yat-sen University Cancer Center","place":["Guangzhou, Guangdong, China"]},{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Hepatobiliary Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1186\/s12885-025-14484-3","article-title":"Certain pMMR colorectal cancer patients should undergo additional MSI-PCR testing to reduce the risk of misdiagnosing MSI-H and Lynch syndrome","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.237","article-title":"Microsatellite instability in colorectal cancer-the stable evidence","volume":"7","author":"Vilar","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3878","article-title":"Milestones of lynch syndrome: 1895-2015","volume":"15","author":"Lynch","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0599-y","article-title":"Immune checkpoint inhibitors for the treatment of MSI-H\/MMR-D colorectal cancer and a perspective on resistance mechanisms","volume":"121","author":"Sahin","year":"2019","journal-title":"Br J Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/gastro\/goz061","article-title":"Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours","volume":"8","author":"Huyghe","year":"2020","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-018-0864-3","article-title":"Biomarkers for predicting efficacy of PD-1\/PD-L1 inhibitors","volume":"17","author":"Yi","year":"2018","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"goae106","DOI":"10.1093\/gastro\/goae106","article-title":"Current status of serum metabolites biomarkers for polyps and colorectal cancer: a systematic review","volume":"12","author":"Abu Bakar","year":"2023","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","article-title":"MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma","volume":"41","author":"Qian","year":"2023","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321031","article-title":"Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/gastro\/goab010","article-title":"Gastrointestinal cancers in China, the USA, and europe","volume":"9","author":"Xie","year":"2021","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2017.04.003","article-title":"Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries","volume":"46","author":"Ho","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3945\/an.110.1008","article-title":"Functional amino acids in growth, reproduction, and health","volume":"1","author":"Wu","year":"2010","journal-title":"Adv Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0342-8","article-title":"Multifaceted roles of PGE2 in inflammation and cancer","volume":"35","author":"Nakanishi","year":"2013","journal-title":"Semin Immunopathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07254-x","article-title":"PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells","volume":"629","author":"Lacher","year":"2024","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12885-025-13908-4","article-title":"L-arginine dependence of breast cancer - molecular subtypes matter","volume":"25","author":"Hannemann","year":"2025","journal-title":"BMC Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2012.07.012","article-title":"Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1","volume":"12","author":"Qualls","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e004420","DOI":"10.1136\/jitc-2021-004420","article-title":"Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model","volume":"10","author":"Azuma","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.gastro.2008.09.062","article-title":"Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages","volume":"136","author":"Andou","year":"2009","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2326-6066.CIR-19-0041","article-title":"Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors","volume":"8","author":"Schramme","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-0459","article-title":"Fueling T-cell antitumor immunity: amino acid metabolism revisited","volume":"9","author":"Han","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2012.11.018","article-title":"Altered functions of natural killer cells in response to L-Arginine availability","volume":"280","author":"Lamas","year":"2012","journal-title":"Cell Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.001","article-title":"Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors","volume":"33","author":"Peyraud","year":"2022","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1730155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:23:46Z","timestamp":1771478626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1730155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":32,"alternative-id":["10.3389\/fonc.2026.1730155"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1730155","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"1730155"}}